- Longer-term follow-up data demonstrate consistent and durable response to treatment -BOSTON (BUSINESS WIRE) Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced two oral presentations at the American Society of Hematology (ASH) Annual Meeting and Exposition from the global pivotal trials of CASGEVY.
- New data including longer duration follow-up from SCD and TDT pivotal trials accepted for oral presentation –
- Five additional abstracts accepted for poster presentation -
.
federalregister.gov - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from federalregister.gov Daily Mail and Mail on Sunday newspapers.
CloudMD Shares Results of Ontario Therapist Assisted Internet Delivered Cognitive Behavioural Therapy Program streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.